Renal Epithelial Complement C3 Expression Affects Kidney Fibrosis Progression

• Published in: International journal of molecular sciences 2024-12, Vol.25 (23), p.12551
• Main Authors: Stepanova, Ganna, Manzéger, Anna, Mózes, Miklós M, Kökény, Gábor
• Format: Article
• Language: English
• Subjects: Analysis; Animals; Atrophy; Chronic kidney failure; Collagen; Complement C3 - genetics; Complement C3 - metabolism; Development and progression; Disease Models, Animal; Disease Progression; Early Growth Response Protein 1 - genetics; Early Growth Response Protein 1 - metabolism; Epithelial Cells - metabolism; Epithelial Cells - pathology; Epithelial-Mesenchymal Transition; Female; Fibrosis; Gene expression; Humans; Kidney - metabolism; Kidney - pathology; Kidney diseases; Kidney Diseases - etiology; Kidney Diseases - genetics; Kidney Diseases - metabolism; Kidney Diseases - pathology; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Proteins; RNA; Stem cells; Transcription factors; Transforming growth factors; Ureteral Obstruction - genetics; Ureteral Obstruction - metabolism; Ureteral Obstruction - pathology
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms252312551

Kidney fibrosis is a hallmark of chronic kidney diseases. Evidence shows that genetic variability and complement component 3 (C3) might influence tubulointerstitial fibrosis. Still, the role of renal C3 production in the epithelial-to-mesenchymal transition (EMT) and genetically determined fibrosis progression remains undiscovered. The kidneys of fibrosis-resistant C57Bl/6J (B6) and fibrosis-prone CBA/J (CBA) and BALB/cJ (BalbC) mice (n = 4-8/group) were subjected to unilateral ureteral obstruction (UUO) and analyzed after 1, 3, and 7 days, along with human focal glomerular sclerotic (FSGS) and healthy kidneys. Mouse primary tubular epithelial cells (PTECs) were investigated after 24 h of treatment with transforming growth factor β (TGFβ) or complement anaphylatoxin 3a (C3a) agonist (n = 4/group). UUO resulted in delayed kidney injury in fibrosis-resistant B6 mice, but very early renal C3 messenger RNA (mRNA) induction in fibrosis-prone CBA and BalbC mice, along with collagen I (Col1a1) and collagen III (Col3a1). CBA depicted the fastest fibrosis progression with the highest C3, lipocalin-2 (Lcn2), Tgfb1, and chemokine (C-C motif) ligand 2 (Ccl2) expression. Human FSGS kidneys depicted C3 mRNA over-expression and strong tubular C3 immunostaining. In PTECs, C3a agonist treatment induced pro-fibrotic early growth response protein 1 (EGR1) expression and the EMT, independent of TGFβ signaling. We conclude that de novo renal tubular C3 synthesis is associated with the genetically determined kidney fibrosis progression rate in mice and the pathogenesis of FSGS in humans. This tubular C3 overproduction can, through local pro-fibrotic effects, influence the progression of chronic kidney disease.